Home Other Building Blocks 139290-65-6
139290-65-6,MFCD00909060
Catalog No.:AA001AMB

139290-65-6 | Mdl 100907

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥95%
in stock  
$79.00   $55.00
- +
5mg
98%
in stock  
$132.00   $93.00
- +
25mg
98%
in stock  
$339.00   $237.00
- +
100mg
98%
in stock  
$815.00   $570.00
- +
1g
98%
in stock  
$3,124.00   $2,187.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA001AMB
Chemical Name:
Mdl 100907
CAS Number:
139290-65-6
Molecular Formula:
C22H28FNO3
Molecular Weight:
373.4610
MDL Number:
MFCD00909060
SMILES:
COc1cccc(c1OC)[C@@H](C1CCN(CC1)CCc1ccc(cc1)F)O
Properties
Properties
 
BP:
499.4°C at 760 mmHg  
Form:
Solid  
MP:
89-91°C  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
422  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Heavy Atom Count:
27  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
7  
XLogP3:
3.9  

Literature

Title: Profiling 976 ToxCast chemicals across 331 enzymatic and receptor signaling assays.

Journal: Chemical research in toxicology 20130617

Title: 5-HT(2A) receptor blockade and 5-HT(2C) receptor activation interact to reduce cocaine hyperlocomotion and Fos protein expression in the caudate-putamen.

Journal: Synapse (New York, N.Y.) 20121201

Title: 5-HT2A receptors in the orbitofrontal cortex facilitate reversal learning and contribute to the beneficial cognitive effects of chronic citalopram treatment in rats.

Journal: The international journal of neuropsychopharmacology 20121001

Title: Involvement of 5-HT2A receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow.

Journal: Synapse (New York, N.Y.) 20120701

Title: Effects of the 5-HT2C receptor agonist Ro60-0175 and the 5-HT2A receptor antagonist M100907 on nicotine self-administration and reinstatement.

Journal: Neuropharmacology 20120601

Title: Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120501

Title: Effects of the selective 5-HT(7) receptor antagonist SB-269970 in animal models of psychosis and cognition.

Journal: Behavioural brain research 20120301

Title: The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine ('ecstasy'): a concurrent microdialysis and plasma analysis study.

Journal: Hormones and behavior 20120201

Title: 5-HT2A receptor antagonist M100907 reduces serotonin synthesis: an autoradiographic study.

Journal: Brain research bulletin 20120104

Title: Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tone.

Journal: NeuroImage 20120102

Title: Dorsal-striatal 5-HT₂A and 5-HT₂C receptors control impulsivity and perseverative responding in the 5-choice serial reaction time task.

Journal: Psychopharmacology 20120101

Title: The 5-HT(2A) receptor and serotonin transporter in Asperger's disorder: A PET study with [¹¹C]MDL 100907 and [¹¹C]DASB.

Journal: Psychiatry research 20111230

Title: Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL 100907.

Journal: Biological psychiatry 20111101

Title: p-Hydroxyamphetamine causes prepulse inhibition disruption in mice: contribution of serotonin neurotransmission.

Journal: Behavioural brain research 20111010

Title: Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease.

Journal: Behavioural pharmacology 20111001

Title: Impulsive action induced by amphetamine, cocaine and MK801 is reduced by 5-HT(2C) receptor stimulation and 5-HT(2A) receptor blockade.

Journal: Neuropharmacology 20110901

Title: Serotonin 2A receptor antagonists for treatment of schizophrenia.

Journal: Expert opinion on investigational drugs 20110901

Title: Serotonin control of sleep-wake behavior.

Journal: Sleep medicine reviews 20110801

Title: Effects of 5-HT(2A) and 5-HT(2C) receptor antagonists on acute and chronic dyskinetic effects induced by haloperidol in rats.

Journal: Behavioural brain research 20110601

Title: Serotonin (5-hydroxytryptamine) 5-HT(2A) receptor: association with inherent and cocaine-evoked behavioral disinhibition in rats.

Journal: Behavioural pharmacology 20110601

Title: Effects of direct- and indirect-acting serotonin receptor agonists on the antinociceptive and discriminative stimulus effects of morphine in rhesus monkeys.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20110401

Title: Blockade of nucleus accumbens 5-HT2A and 5-HT2C receptors prevents the expression of cocaine-induced behavioral and neurochemical sensitization in rats.

Journal: Psychopharmacology 20110201

Title: Blockade of 5-HT2A receptors in the medial prefrontal cortex attenuates reinstatement of cue-elicited cocaine-seeking behavior in rats.

Journal: Psychopharmacology 20110201

Title: P-glycoprotein influence on the brain uptake of a 5-HT(2A) ligand: [(18)F]MH.MZ.

Journal: Neuropsychobiology 20110101

Title: Possible involvement of serotonin 5-HT2 receptor in the regulation of feeding behavior through the histaminergic system.

Journal: Neuropharmacology 20110101

Title: Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice.

Journal: The Journal of pharmacology and experimental therapeutics 20101201

Title: Novel spirotetracyclic zwitterionic dual H(1)/5-HT(2A) receptor antagonists for the treatment of sleep disorders.

Journal: Journal of medicinal chemistry 20101111

Title: The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20101001

Title: Structural combination of established 5-HT(2A) receptor ligands: new aspects of the binding mode.

Journal: Chemical biology & drug design 20101001

Title: Differential effects of serotonin (5-HT)2 receptor-targeting ligands on locomotor responses to nicotine-repeated treatment.

Journal: Synapse (New York, N.Y.) 20100701

Title: Synergistic effect of decreased opioid activity and sleep deprivation on head-twitch response in mice.

Journal: Pharmacology, biochemistry, and behavior 20100701

Title: Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients.

Journal: Biological psychiatry 20100615

Title: Non-basic ligands for aminergic GPCRs: the discovery and development diaryl sulfones as selective, orally bioavailable 5-HT2A receptor antagonists for the treatment of sleep disorders.

Journal: Bioorganic & medicinal chemistry letters 20100615

Title: CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling.

Journal: Nature neuroscience 20100501

Title: 18F-labeling and evaluation of novel MDL 100907 derivatives as potential 5-HT2A antagonists for molecular imaging.

Journal: Nuclear medicine and biology 20100501

Title: Simplified quantification of 5-HT2A receptors in the human brain with [11C]MDL 100,907 PET and non-invasive kinetic analyses.

Journal: NeuroImage 20100415

Title: Antagonism at serotonin 5-HT(2A) receptors modulates functional activity of frontohippocampal circuit.

Journal: Psychopharmacology 20100301

Title: Attenuation of phencyclidine-induced object recognition deficits by the combination of atypical antipsychotic drugs and pimavanserin (ACP 103), a 5-hydroxytryptamine(2A) receptor inverse agonist.

Journal: The Journal of pharmacology and experimental therapeutics 20100201

Title: Blockade of serotonin 2A receptors prevents PCP-induced attentional performance deficit and CREB phosphorylation in the dorsal striatum of DBA/2 mice.

Journal: Psychopharmacology 20100201

Title: Enhancement of spatial reversal learning by 5-HT2C receptor antagonism is neuroanatomically specific.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20100120

Title: Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms.

Journal: Psychopharmacology 20100101

Title: 5-HT2A receptor antagonists improve motor impairments in the MPTP mouse model of Parkinson's disease.

Journal: Neuropharmacology 20100101

Title: Plaque deposition dependent decrease in 5-HT2A serotonin receptor in AbetaPPswe/PS1dE9 amyloid overexpressing mice.

Journal: Journal of Alzheimer's disease : JAD 20100101

Title: Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), ketanserin, and (R)-(+)-{alpha}-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in rats.

Journal: The Journal of pharmacology and experimental therapeutics 20091101

Title: Combined administration of an mGlu2/3 receptor agonist and a 5-HT 2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants.

Journal: Psychopharmacology 20091101

Title: Enhanced 5-HT(2A) receptors in brain stem and ALDH activity in brain stem and liver: 5-HT(2A) regulation on ALDH in primary hepatocytes cultures in vitro.

Journal: Neurochemical research 20090901

Title: Effect of sertindole on extracellular dopamine, acetylcholine, and glutamate in the medial prefrontal cortex of conscious rats: a comparison with risperidone and exploration of mechanisms involved.

Journal: Psychopharmacology 20090901

Title: Serotonergic hyperinnervation and effective serotonin blockade in an FGF receptor developmental model of psychosis.

Journal: Schizophrenia research 20090901

Title: Interactions of serotonin (5-HT)2 receptor-targeting ligands and nicotine: locomotor activity studies in rats.

Journal: Synapse (New York, N.Y.) 20090801

Title: Role of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates.

Journal: Psychopharmacology 20090801

Title: Side chain flexibilities in the human ether-a-go-go related gene potassium channel (hERG) together with matched-pair binding studies suggest a new binding mode for channel blockers.

Journal: Journal of medicinal chemistry 20090723

Title: Relevance of dorsal raphe nucleus firing in serotonin 5-HT(2C) receptor blockade-induced augmentation of SSRIs effects.

Journal: Neuropharmacology 20090701

Title: Activation of glucocorticoid receptors increases 5-HT2A receptor levels.

Journal: Experimental neurology 20090701

Title: Activation of the JAK-STAT pathway is necessary for desensitization of 5-HT2A receptor-stimulated phospholipase C signalling by olanzapine, clozapine and MDL 100907.

Journal: The international journal of neuropsychopharmacology 20090601

Title: The brain 5-HT4 receptor binding is down-regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration.

Journal: Journal of neurochemistry 20090601

Title: Simultaneous telemetric monitoring of tail-skin and core body temperature in a rat model of thermoregulatory dysfunction.

Journal: Journal of neuroscience methods 20090415

Title: Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.

Journal: Bioorganic & medicinal chemistry 20090415

Title: Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload.

Journal: Journal of molecular and cellular cardiology 20090401

Title: Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model.

Journal: Behavioral neuroscience 20090401

Title: Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys: antagonism and apparent pA2 analyses.

Journal: The Journal of pharmacology and experimental therapeutics 20090301

Title: Pharmacological properties and discriminative stimulus effects of a novel and selective 5-HT2 receptor agonist AL-38022A [(S)-2-(8,9-dihydro-7H-pyrano[2,3-g]indazol-1-yl)-1-methylethylamine].

Journal: Pharmacology, biochemistry, and behavior 20090101

Title: Endogenous serotonin and serotonin2C receptors are involved in the ability of M100907 to suppress cortical glutamate release induced by NMDA receptor blockade.

Journal: Journal of neurochemistry 20090101

Title: Fluoxetine-mediated 5-HT2B receptor stimulation in astrocytes causes EGF receptor transactivation and ERK phosphorylation.

Journal: Psychopharmacology 20081201

Title: The 5-hydroxytryptamine2A receptor antagonist R-(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl-4-piperidinemethanol (M100907) attenuates impulsivity after both drug-induced disruption (dizocilpine) and enhancement (antidepressant drugs) of differential-reinforcement-of-low-rate 72-s behavior in the rat.

Journal: The Journal of pharmacology and experimental therapeutics 20081201

Title: Validation of a rat in vivo [(3)H]M100907 binding assay to determine a translatable measure of 5-HT(2A) receptor occupancy.

Journal: European journal of pharmacology 20080904

Title: Opposing roles for 5-HT2A and 5-HT2C receptors in the nucleus accumbens on inhibitory response control in the 5-choice serial reaction time task.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20080901

Title: The hallucinogen DOI reduces low-frequency oscillations in rat prefrontal cortex: reversal by antipsychotic drugs.

Journal: Biological psychiatry 20080901

Title: Chronic phenethylamine hallucinogen treatment alters behavioral sensitivity to a metabotropic glutamate 2/3 receptor agonist.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20080801

Title: Dissociable effects of selective 5-HT2A and 5-HT2C receptor antagonists on serial spatial reversal learning in rats.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20080701

Title: Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.

Journal: The Journal of pharmacology and experimental therapeutics 20080501

Title: Evidence that genetic variation in 5-HT transporter expression is linked to changes in 5-HT2A receptor function.

Journal: Neuropharmacology 20080401

Title: 2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists.

Journal: Bioorganic & medicinal chemistry letters 20080315

Title: Total synthesis and evaluation of [18F]MHMZ.

Journal: Bioorganic & medicinal chemistry letters 20080215

Title: Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: differential efficacy depending on the stage of the task at which they are administered.

Journal: Psychopharmacology 20080201

Title: In vivo pharmacology of MDMA and its enantiomers in rhesus monkeys.

Journal: Experimental and clinical psychopharmacology 20080201

Title: Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents.

Journal: Pharmacology, biochemistry, and behavior 20080101

Title: The stimulus effects of 8-OH-DPAT: evidence for a 5-HT2A receptor-mediated component.

Journal: Pharmacology, biochemistry, and behavior 20080101

Title: Selective 5HT2A and 5HT6 receptor antagonists promote sleep in rats.

Journal: Sleep 20080101

Title: Effects of 5-HT drugs in prefrontal cortex during memory formation and the ketamine amnesia-model.

Journal: Hippocampus 20080101

Title: 5-HT(2A) inverse-agonists for the treatment of insomnia.

Journal: Current topics in medicinal chemistry 20080101

Title: Opposing effects of 5-HT(2A) and 5-HT(2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test.

Journal: Psychopharmacology 20071201

Title: Behavioral response to emotional stress in rabbits: role of serotonin and serotonin2A receptors.

Journal: Behavioural pharmacology 20071101

Title: Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.

Journal: European journal of pharmacology 20071001

Title: Hippocampal Bcl-2 expression is selectively increased following chronic but not acute treatment with antidepressants, 5-HT(1A) or 5-HT(2C/2B) receptor antagonists.

Journal: European journal of pharmacology 20070813

Title: Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A-/-, 5-HT1B-/-, 5-HT2A-/-, 5-HT3A-/- and 5-HTT-/- knock-out male mice.

Journal: Pain 20070801

Title: Behavioral effects of dipropyltryptamine in rats: evidence for 5-HT1A and 5-HT2A agonist activity.

Journal: Behavioural pharmacology 20070701

Title: Blockade of 5-HT2a receptors reduces haloperidol-induced attenuation of reward.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070301

Title: 5-Hydroxytryptamine (serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of d-lysergic acid diethylamide.

Journal: The Journal of pharmacology and experimental therapeutics 20070201

Title: Validation of a tracer kinetic model for the quantification of 5-HT(2A) receptors in human brain with [(11)C]MDL 100,907.

Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20070101

Title: Effects of d-amphetamine and DOI (2,5-dimethoxy-4-iodoamphetamine) on timing behavior: interaction between D1 and 5-HT2A receptors.

Journal: Psychopharmacology 20061201

Title: Cardiac baroreflex facilitation evoked by hypothalamus and prefrontal cortex stimulation: role of the nucleus tractus solitarius 5-HT2A receptors.

Journal: American journal of physiology. Regulatory, integrative and comparative physiology 20061001

Title: Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907.

Journal: The American journal of psychiatry 20060901

Title: Serotonin 2A receptor antagonist treatment reduces dopamine D1 receptor-mediated rotational behavior but not L-DOPA-induced abnormal involuntary movements in the unilateral dopamine-depleted rat.

Journal: Neuropharmacology 20060501

Title: Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060401

Title: Effects of 5-HT2A receptor stimulation on the discrimination of durations by rats.

Journal: Behavioural pharmacology 20060201

Title: Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats.

Journal: Pharmacology, biochemistry, and behavior 20060101

Title: Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.

Journal: Synapse (New York, N.Y.) 20051215

Title: Use of LC/MS to assess brain tracer distribution in preclinical, in vivo receptor occupancy studies: dopamine D2, serotonin 2A and NK-1 receptors as examples.

Journal: Life sciences 20051212

Title: The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20051201

Title: Relationship of cocaine-induced c-Fos expression to behaviors and the role of serotonin 5-HT2A receptors in cocaine-induced c-Fos expression.

Journal: Behavioral neuroscience 20051001

Title: The role of 5-HT(2A) receptor antagonism in amphetamine-induced inhibition of A10 dopamine neurons in vitro.

Journal: European journal of pharmacology 20050927

Title: Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050901

Title: Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958.

Journal: Neuropharmacology 20050901

Title: Serotonergic regulation of calcium-activated potassium currents in rodent prefrontal cortex.

Journal: The European journal of neuroscience 20050901

Title: 4-Fluorosulfonylpiperidines: selective 5-HT2A ligands for the treatment of insomnia.

Journal: Bioorganic & medicinal chemistry letters 20050815

Title: The stimulus properties of LSD in C57BL/6 mice.

Journal: Pharmacology, biochemistry, and behavior 20050801

Title: Lithium differs from anticonvulsant mood stabilizers in prefrontal cortical and accumbal dopamine release: role of 5-HT(1A) receptor agonism.

Journal: Brain research 20050712

Title: Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.

Journal: Psychopharmacology 20050701

Title: A role for midbrain raphe gamma aminobutyric acid neurons in 5-hydroxytryptamine feedback control.

Journal: Neuroreport 20050621

Title: Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.

Journal: Psychopharmacology 20050601

Title: Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine.

Journal: Psychopharmacology 20050401

Title: Serotonin 2A receptors modulate tail-skin temperature in two rodent models of estrogen deficiency-related thermoregulatory dysfunction.

Journal: Brain research 20041203

Title: 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion.

Journal: Psychopharmacology 20041101

Title: The 5-HT receptor antagonist M100,907 prevents extracellular glutamate rising in response to NMDA receptor blockade in the mPFC.

Journal: Journal of neurochemistry 20041001

Title: Cutting edge: serotonin is a chemotactic factor for eosinophils and functions additively with eotaxin.

Journal: Journal of immunology (Baltimore, Md. : 1950) 20040915

Title: The serotonin 5-HT2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20040901

Title: Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.

Journal: Naunyn-Schmiedeberg's archives of pharmacology 20040801

Title: Desensitization of 5-HT1A receptors by 5-HT2A receptors in neuroendocrine neurons in vivo.

Journal: The Journal of pharmacology and experimental therapeutics 20040701

Title: Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice.

Journal: Psychopharmacology 20040501

Title: Serotonergic facilitation of synaptic activity in the developing rat prefrontal cortex.

Journal: The Journal of physiology 20040501

Title: The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20040201

Title: Discriminative stimulus properties of 1.25 and 5.0 mg/kg doses of clozapine in rats: examination of the role of dopamine, serotonin, and muscarinic receptor mechanisms.

Journal: Pharmacology, biochemistry, and behavior 20040201

Title: Fenfluramine evokes 5-HT2A receptor-mediated responses but does not displace [11C]MDL 100907: small animal PET and gene expression studies.

Journal: Synapse (New York, N.Y.) 20031201

Title: The 5-HT2A receptor antagonist M100,907 attenuates motor and 'impulsive-type' behaviours produced by NMDA receptor antagonism.

Journal: Psychopharmacology 20031101

Title: Pharmacological characterization of a serotonin receptor (5-HT7) stimulating cAMP production in human corneal epithelial cells.

Journal: Investigative ophthalmology & visual science 20031101

Title: Group II metabotropic glutamate receptor antagonists LY341495 and LY366457 increase locomotor activity in mice.

Journal: Neuropharmacology 20031001

Title: Latent inhibition in 35-day-old rats is not an 'adult' latent inhibition: implications for neurodevelopmental models of schizophrenia.

Journal: Psychopharmacology 20030901

Title: In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT(2A) receptors: effect of antipsychotic drugs.

Journal: The European journal of neuroscience 20030901

Title: The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats.

Journal: Neuroscience letters 20030807

Title: Regulation of septo-hippocampal activity by 5-hydroxytryptamine(2C) receptors.

Journal: The Journal of pharmacology and experimental therapeutics 20030801

Title: Evaluation of the ocular hypotensive response of serotonin 5-HT1A and 5-HT2 receptor ligands in conscious ocular hypertensive cynomolgus monkeys.

Journal: The Journal of pharmacology and experimental therapeutics 20030701

Title: 5-HT 2A receptor stimulation by DOI, a 5-HT 2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.

Journal: Brain research 20030516

Title: Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats.

Journal: Psychopharmacology 20030501

Title: Generalization of clozapine as compared to other antipsychotic agents to a discriminative stimulus elicited by the serotonin (5-HT)2A antagonist, MDL100,907.

Journal: Neuropharmacology 20030401

Title: Discriminative stimulus properties of (+/-)-fenfluramine: the role of 5-HT2 receptor subtypes.

Journal: Behavioral neuroscience 20030401

Title: Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ('ecstasy') and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice.

Journal: Psychopharmacology 20030301

Title: Neuroendocrine evidence that (S)-2-(chloro-5-fluoro-indol- l-yl)-1-methylethylamine fumarate (Ro 60-0175) is not a selective 5-hydroxytryptamine(2C) receptor agonist.

Journal: The Journal of pharmacology and experimental therapeutics 20030301

Title: Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(+/-)DOI] in C57BL/6J mice.

Journal: Psychopharmacology 20030201

Title: Protein kinase C is involved in clozapine's facilitation of N-methyl-D-aspartate- and electrically evoked responses in pyramidal cells of the medial prefrontal cortex.

Journal: Neuroscience 20030101

Title: Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells.

Journal: The American journal of pathology 20021201

Title: Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20021101

Title: Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20021001

Title: SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020901

Title: 5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner.

Journal: Brain research 20020830

Title: 5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex.

Journal: Brain research 20020607

Title: Synthesis, receptor potency, and selectivity of halogenated diphenylpiperidines as serotonin 5-HT2A ligands for PET or SPECT brain imaging.

Journal: Journal of medicinal chemistry 20020523

Title: The selective serotonin(2A) receptor antagonist, MDL100,907, elicits a specific interoceptive cue in rats.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020401

Title: Attenuation of ischemic efflux of endogenous amino acids by the novel 5-HT(1A)/5-HT(2) receptor ligand adatanserin.

Journal: Neurochemistry international 20020301

Title: Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)(2) receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT(2A) receptor mediation of the HPA axis.

Journal: Neuropharmacology 20020201

Title: 4-(Phenylsulfonyl)piperidines: novel, selective, and bioavailable 5-HT(2A) receptor antagonists.

Journal: Journal of medicinal chemistry 20020117

Title: Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020101

Title: Effects of phencyclidine (PCP) and MK 801 on the EEGq in the prefrontal cortex of conscious rats; antagonism by clozapine, and antagonists of AMPA-, alpha(1)- and 5-HT(2A)-receptors.

Journal: British journal of pharmacology 20020101

Title: Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20011215

Title: Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons.

Journal: Brain research 20011213

Title: m-CPP hypolocomotion is selectively antagonized by compounds with high affinity for 5-HT(2C) receptors but not 5-HT(2A) or 5-HT(2B) receptors.

Journal: Behavioural pharmacology 20011201

Title: Effect of clozapine, haloperidol, or M100907 on phencyclidine-activated glutamate efflux in the prefrontal cortex.

Journal: Biological psychiatry 20011115

Title: Characterization of the functional heterologous desensitization of hypothalamic 5-HT(1A) receptors after 5-HT(2A) receptor activation.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20011015

Title: Multiple conformations of native and recombinant human 5-hydroxytryptamine(2a) receptors are labeled by agonists and discriminated by antagonists.

Journal: Molecular pharmacology 20011001

Title: Differential regulation of the mesoaccumbens circuit by serotonin 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20011001

Title: DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release.

Journal: Brain research 20010713

Title: 5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20010515

Title: Acute and repeated administration of the selective 5-HT(2A) receptor antagonist M100907 significantly alters the activity of midbrain dopamine neurons: an in vivo electrophysiological study.

Journal: Synapse (New York, N.Y.) 20010501

Title: M100907, a selective 5-HT(2A) receptor antagonist, attenuates phencyclidine-induced Fos expression in discrete regions of rat brain.

Journal: European journal of pharmacology 20010413

Title: Antagonism of 5-hydroxytryptamine(2a) receptors attenuates the behavioral effects of cocaine in rats.

Journal: The Journal of pharmacology and experimental therapeutics 20010401

Title: [Synthesis and biological activities of new 5-HT2A selective ligands--N-substituted-piperidinyl-4-phenylthioether and sulfone derivatives].

Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20010401

Title: Role of 5-HT(2a) and 5-HT(2B/2C) receptors in the behavioral interactions between serotonin and catecholamine reuptake inhibitors.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20010301

Title: Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats.

Journal: Pharmacology, biochemistry, and behavior 20010301

Title: Current and novel approaches to the drug treatment of schizophrenia.

Journal: Journal of medicinal chemistry 20010215

Title: Mapping of 5-HT2A receptors and their mRNA in monkey brain: [3H]MDL100,907 autoradiography and in situ hybridization studies.

Journal: The Journal of comparative neurology 20010122

Title: M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex.

Journal: Brain research 20010105

Title: M-100907 (Aventis).

Journal: Current opinion in investigational drugs (London, England : 2000) 20010101

Title: A behavioural pattern analysis of hypoglutamatergic mice--effects of four different antipsychotic agents.

Journal: Journal of neural transmission (Vienna, Austria : 1996) 20010101

Title: Autoradiographic localization of 5-HT(2A) receptors in the human brain using [(3)H]M100907 and [(11)C]M100907.

Journal: Synapse (New York, N.Y.) 20001215

Title: 5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB.

Journal: Pharmacology, biochemistry, and behavior 19990601

Title: Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist.

Journal: British journal of pharmacology 19990201

Title: Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptor.

Journal: The Journal of pharmacology and experimental therapeutics 19951101

Title: Sorensen SM, et al. Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies. J Pharmacol Exp Ther. 1993 Aug;266(2):684-91.

Title: Ardayfio PA, et al. The 5-hydroxytryptamine2A receptor antagonist R-(+)-alpha-(2,3-dimethoxyphenyl)-1--(4-fluorophenyl)ethyl-4-piperidinemethanol (M100907) attenuates impulsivity after both drug-induced disruption (dizocilpine) and enhancement (antidepressant drugs) of differential-reinforcement-of-low-rate 72-s behavior in the rat. J Pharmacol Exp Ther. 2008 Dec;327(3):891-7.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:139290-65-6 Molecular Formula|139290-65-6 MDL|139290-65-6 SMILES|139290-65-6 Mdl 100907